Finance

Lists
Why is CTX up 3,90%?
Dive Deeper
CTX:WSE
Captor Therapeutics SA
PLN 58,60
+3,90%
(+2,20) 1D
20 Okt., 17:00:58 GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CTX...
Open
PLN 55,80
High
PLN 59,60
Low
PLN 55,20
Mkt. cap
372,31 m
Avg. vol.
6,25 k
Volume
3,79 k
52-wk high
PLN 80,00
52-wk low
PLN 45,00
EPS
-PLN 7,77
Shares outstanding
6,35 m
No. of employees
82
Open
PLN 55,80
High
PLN 59,60
Low
PLN 55,20
Mkt. cap
372,31 m
Avg. vol.
6,25 k
Volume
3,79 k
52-wk high
PLN 80,00
52-wk low
PLN 45,00
EPS
-PLN 7,77
Shares outstanding
6,35 m
No. of employees
82
News stories
From web sources and news partners
About Captor Therapeutics SA
CEO-
Employees82
Founded2015
Headquarters-
Sector-
Last report
15 Sep. 2026
Fiscal period
Q2 2026
- / -
Revenue / Est. (PLN)
1,63 m / 1,50 m
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
44,00 k
328,00 k
1,63 m
Cost of goods sold
-2,02 m
-
-
173,00 k
Cost of revenue
-2,02 m
-
-
173,00 k
Research and development expenses
14,74 m
9,82 m
10,56 m
13,78 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,37 m
2,53 m
1,92 m
2,25 m
Operating expense
13,83 m
10,40 m
11,59 m
14,39 m
Total operating expenses
11,81 m
10,40 m
11,59 m
14,56 m
Operating income
-11,81 m
-10,36 m
-11,26 m
-12,93 m
Other non operating income
1,00 k
-8,00 k
-
-
EBT including unusual items
-11,48 m
-10,05 m
-11,35 m
-11,39 m
EBT excluding unusual items
-11,48 m
-10,12 m
-11,35 m
-11,39 m
Income tax expense
-
-
27,00 k
-
Effective tax rate
-
-
-0,24%
-
Other operating expenses
-2,27 m
-1,94 m
-893,00 k
-1,64 m
Net income
-11,48 m
-10,05 m
-11,38 m
-11,39 m
Net profit margin
-
-22 831,82%
-3 467,99%
-696,88%
Earnings per share
-
-
-
-
Interest and investment income
391,00 k
303,00 k
39,00 k
1,63 m
Interest expense
-61,00 k
-75,00 k
-67,00 k
-57,00 k
Net interest expenses
330,00 k
228,00 k
-28,00 k
1,57 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-10,81 m
-9,53 m
-10,36 m
-12,04 m
Gain or loss from assets sale
-682,00 k
-
-
-128,00 k
AI content may include mistakes. Learn more
Google-programme